New Slow-Release pyridostigmine tablet tested in healthy volunteers
NCT ID NCT07154095
First seen Nov 01, 2025 · Last updated May 05, 2026 · Updated 25 times
Summary
This study tested a new slow-release version of the drug pyridostigmine in 40 healthy adults. The goal was to see how the body processes the new tablet compared to the regular one, and to check for any side effects. Participants took both versions at different times so the researchers could compare drug levels in the blood. This is an early-stage study that does not involve treating any disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PHARMACOKINETICS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Second University Hospital
Chengdu, China
Conditions
Explore the condition pages connected to this study.